Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.

Int J Antimicrob Agents · 2022 · PMC8817946 · PMID 35134505

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although patients receiving sofosbuvir-based treatment had a lower risk of requiring MV than the control group, the difference did not reach statistical significance (OR = 0.36, 95% CI 0.13–1.02; I 2 = 0%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.